read more

first_img Related Content Gamma Medica Inc. will demonstrate the LumaGEM Low Dose Molecular Breast Imaging (MBI) System at RSNA 2012. LumaGEM MBI is the first commercially available, U.S. Food and Drug Administration (FDA)-cleared, planar, dual-head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for digital breast imaging.  LumaGEM Low Dose MBI is a major advancement in the area of molecular imaging, identifying tumors in dense breast tissue that are often not visible with mammography. A 2011 publication in Radiology (doi:10.1148/radiol.10100625), documented the addition of molecular breast imaging (MBI) in 1,000 patients, following an injection of 20 mCi Tc-99m sestamibi, to screening mammography (MG) significantly increased detection of breast cancer in dense breasts from 27 percent with MG alone to 91 percent with the combination (p=0.016).After implementing modifications that permit further radiation dose reduction, performance has been clinically compared between screen mammography and prevalent screen low-dose MBI in 2,400 women with dense breasts using an 8 mCi injection of Tc-99m sestamibi, dual-head CZT detectors by Gamma Medica, and acquired in dynamic frames to allow the generation of 4 mCi equivalent images.For more information: FacebookTwitterLinkedInPrint分享 Image courtesy of Imago Systems read more News | Ultrasound Women’s Health | July 11, 2019 FDA Clears Koios DS Breast 2.0 AI-based Software Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA). IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology. News | Mammography Reporting Software | July 26, 2019 Ikonopedia Releases Automated Combined Reporting Package at AHRA Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured… read more News | Artificial Intelligence | July 03, 2019 Therapixel Appoints Matthieu Leclerc-Chalvet as CEO Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu… read more Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire. News | Breast Imaging | August 02, 2019 Volpara to Distribute Screenpoint Medical’s Transpara AI Solution Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint’s Transpara… read more Technology | Breast Biopsy Systems | July 24, 2019 Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its… read more News | Mammography | July 10, 2019 SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-… read more Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev AI Models Predict Breast Cancer With Radiologist-level Accuracy Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer… read more News | Mammography | August 14, 2019 Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year… read more Technology | Artificial Intelligence | July 18, 2019 Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded… read more Technology | Mammography Reporting Software | July 25, 2019 Hologic Partners With MagView to Develop Unifi EQUIP Solution Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an… read more Technology | November 02, 2011 Low Dose Molecular Breast Imaging Aids Tumor Detection last_img read more